HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

PrEP | Image credit: Bowonpat - stock.adobe.com
Researchers Estimate PrEP Needed in the US Across Multiple Subgroups

June 24th 2025

A model that can estimate the need for pre-exposure prophylaxis (PrEP) in the US can help to clarify use patterns to address HIV in local settings.

Colleen Kelley, MD, MPH
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH

June 20th 2025

Image credit: Yale School of Medicine
Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

June 19th 2025

FDA Approved
Twice-Yearly Lenacapavir Approval Marks Major Milestone in Prevention of HIV

June 18th 2025

Zandraetta Tims-Cook
Contributor: PrEP in Practice – How to Start Conversations About HIV Prevention

June 17th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
June 26th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases
June 26th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 26th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
November 15th 2024

BIC/FTC/TAF Effective at Virologic Suppression in HIV Presenting Late

Julia Bonavitacola
The combination therapy of bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF) was both tolerable and produced virologic suppression in patients who were presenting late in their HIV infection.
Liver | Image credit: PIC4U - stock.adobe.com
November 12th 2024

Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV

Julia Bonavitacola
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver conditions are prevalent for these individuals.
Madalitso Juwayeyi
November 8th 2024

Empowering Young Women in the Fight Against HIV

Maggie L. Shaw
As part of our coverage of the biennial AIDS conference from the International AIDS Society, we spoke with Madalitso Juwayeyi, program manager at FACT-Malawi, to learn more about her organization and how it strives to serve the sexual and reproductive health needs of adolescent girls and young women in her native Malawi.
HIV/AIDS | Image credit: SpeedShutter - stock.adobe.com
November 4th 2024

Controlling Spread of Drug-Resistant HIV May Necessitate Interventions

Julia Bonavitacola
Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is drug-resistant.
HIV | Image credit: artegorov3@gmail - stock.adobe.com
October 29th 2024

Relationships Between Neighborhood Stressors, Mental Health Exist in PWH

Julia Bonavitacola
People living with HIV (PWH) can have mental health implications related to their neighborhood markers and environment.
Antiretroviral therapy | Image credit: Мaksim G - stock.adobe.com
October 24th 2024

Drug-Related Problems High in HIV Treatment Failure

Julia Bonavitacola
Treatment effectiveness and safety can be affected by drug-related problems in patients who experience HIV treatment failure.
ICU | Image credit: Kiryl Lis - stock.adobe.com
October 15th 2024

ICU Mortality of People Living With HIV Has Decreased Over Time

Julia Bonavitacola
Patients living with HIV in Barcelona, Spain have seen a decrease in mortality of patients in critically ill condition admitted to the intensive care unit (ICU).
Man holding HIV awareness ribbon | Image credit: Krakenimages.com - stock.adobe.com
October 10th 2024

Lenacapavir Highly Effective in Preventing HIV

Julia Bonavitacola
New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex with men.
Black doctor holds AIDS Awareness Day ribbon | Image credit: Jelena Stanojkovic - stock.adobe.com
October 7th 2024

Bictegravir/Emtricitabine/Tenofovir Alafenamide Maintained Virologic Suppression in Patients With HIV

Julia Bonavitacola
A phase 3b study found that Black individuals who switched to bictegravir/emtricitabine/tenofovir alafenamide were able to maintain virologic suppression after 72 weeks.
HIV treatment | Image credit: jarun011 - stock.adobe.com
October 4th 2024

5 Decades of Notable Achievements in Treatment for HIV/AIDS

Julia Bonavitacola
The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.
Health equity. | Image Credit: Djavan Rodriguez - stock.adobe.com
October 3rd 2024

The Health-Related Consequences of Redlining

Cameron Santoro
The legacy of redlining continues to harm minority health, with Black individuals facing higher rates of health issues, linked to environmental factors and limited access to resources in regions previously redlined.
Q&A With Varsha Srivatsan, MSci, O’Neill Institute for National and Global Health Law
October 2nd 2024

From Criminalization to Compassion: The Evolution of HIV Laws

Maggie L. Shaw
The 25th International AIDS Conference took place July 22-26 in Munich, Germany, and one of the sessions delved into the potential impact of civil society laws on the 95-95-95 targets as laid out in the UNAIDS Global AIDS Strategy for 2021 to 2026.
HIV | Image credit: RAJCREATIONZS - stock.adobe.com
September 30th 2024

Past Redlining Continues to Affect Health Outcomes in Patients With HIV

Julia Bonavitacola
Systemic racism, including the practice of redlining, has had an enduring effect on health outcomes in people living with HIV, including time to viral suppression.
Man with HIV | Image credit: Krakenimages.com - stock.adobe.com
September 27th 2024

Men Living With HIV Experiencing Sexual Difficulties Had Lower Quality of Life

Julia Bonavitacola
Follow-up in men living with HIV who have sex with men should be performed to assess quality of life due to sexual function.
Paul Schaper, MA, MPH, MBA | Image Credit: Merck
September 13th 2024

Fighting HIV Stigma: Empowering Global Leaders for Change

Maggie L. Shaw
In a session at AIDS 2024, the International AIDS Conference, global leaders and community advocates gathered to discuss why stigma and shame continue to attach themselves to an HIV diagnosis and why policy efforts to overcome both must persist.
HIV | Image credit: RAJCREATIONZS - stock.adobe.com
September 12th 2024

National HIV/AIDS Strategy Quality of Life Goals Unlikely to Be Met

Julia Bonavitacola
Goals including addressing all of hunger and food insecurity, unmet needs for mental health services, and unstable housing or homelessness in people living with HIV are unlikely to meet their 2025 thresholds.
Man getting STI test | Image credit: New Africa - stock.adobe.com
September 10th 2024

Bacterial STIs in Men Living With HIV Associated With Drug Use in Sexual Context

Julia Bonavitacola
Drug use, participation in exchange sex, and depressive symptoms were all found to be associated with bacterial sexually transmitted infections (STIs) in sexual minority men living with HIV.
HIV | Image credit: artegorov3@gmail - stock.adobe.com
September 6th 2024

Periodontal Status Not Affected by HIV Infection

Julia Bonavitacola
There were no significant differences found between people with and without HIV when it came to their periodontal profile.
Emmanuel Nazaire Essam, MD, MPH | Image Credit: University of Nebraska Medical Center
September 1st 2024

Improving HIV Outcomes Through Medicaid Expansion

Maggie L. Shaw
At the 25th International AIDS Conference, Emmanuel Nazaire Essam, MD, MPH, presented the analysis, "Medicaid Insurance Expansion and Its Association With HIV Outcomes in Nebraska, USA: An Observational Prospective Cohort Study."
Military | Image credit: roibu - stock.adobe.com
August 22nd 2024

Patients With HIV Can Enlist in the Military, Federal Judge Rules

Julia Bonavitacola
A federal judge determined that all people being actively treated for HIV can enlist in the military.
Kelly Dyer, MD, Perelman School of Medicine
August 21st 2024

Substance Use Disorder and HIV/AIDS: Addressing Dual Crises

Maggie L. Shaw
At AIDS 2024 in July, Kelly Dyer, MD, Perelman School of Medicine, presented research findings from an investigation at the intersection of health equity, substance use detox, infectious disease screening, and patient harm reduction.
Jennifer Cocohoba, PharmD, MAS, AAHIVP | Image Credit: UCSF School of Pharmacy
August 18th 2024

Pharmacy-Based HIV Care: New Frontiers and Patient Views

Maggie L. Shaw
Jennifer Cocohoba, PharmD, MAS, AAHIVP, University of California, San Francisco, School of Pharmacy, discusses the benefits of pharmacy-administered long-acting injectable antiretroviral therapy for HIV and patient attitudes toward pharmacy-administered treatment.
HIV-PrEP | Image Credit: magann-stock.adobe.com
August 14th 2024

Targeted Programming Essential to Boost PrEP Coverage Worldwide

Maggie L. Shaw
A trio of posters presented at AIDS 2024, the 25th International AIDS Conference, explored widespread disparities in access to pre-exposure prophylaxis (PrEP) and how to make access more equitable, both globally and locally.
Nishita Dsouza, PhD, MPH, Columbia University School of Social Work
August 11th 2024

Empowering Black Women Through HIV Prevention

Maggie L. Shaw
For the recent AIDS 2024 conference, we spoke with Nishita Dsouza, PhD, MPH, Columbia University School of Social Work Social Intervention Group, who presented research on HIV and sexually transmitted infection prevention among Black women with criminal legal system involvement.
Musarrat Perveen | Image Credit: CARAM Asia
August 7th 2024

Part 2: Addressing Migrant Workers' Vulnerability to HIV

Maggie L. Shaw
In part 1 of this interview, Musarrat Perveen, regional coordinator at Coordination of Action Research on AIDS and Mobility in Asia (CARAM Asia), explained the research she presented at the 25th International AIDS Conference and the disparities migrant workers continue to encounter in HIV care.
Musarrat Perveen | Image Credit: CARAM Asia
Published: August 5th 2024 | Updated: August 4th 2024

Part 1: Addressing Migrant Workers' Vulnerability to HIV

Maggie L. Shaw
We spoke with Musarrat Perveen, regional coordinator at Coordination of Action Research on AIDS and Mobility in Asia (CARAM Asia), who advocates at regional and global levels for policy reform of discriminatory practices that put migrant workers at risk of HIV and AIDS.
Jacklyn D. Foley, PhD, MS
August 1st 2024

CBT Group Sessions Ease Distress in Older Patients Living With HIV

Maggie L. Shaw
This research presented at AIDS 2024 shows that cognitive behavioral therapy (CBT) groups help to fill an unmet need among older persons living with HIV: to overcome the age-related health disparities this group experiences from being in long-term care and improve their health outcomes.
Patricia A. Cioe, PhD | Image Credit: Brown University School of Public Health
July 28th 2024

Peer Support Boosts Smoking Cessation in HIV

Maggie L. Shaw
Patricia Cioe, PhD, presented data at AIDS 2024 from a study that investigated the impact of peer support on people living with HIV who smoke, a group for whom there are higher rates of cardiac events and cancer.
ARTISTRY-1: Simplifying HIV Treatment for the Most Complex Cases
July 25th 2024

ARTISTRY-1: Simplifying HIV Treatment for the Most Complex Cases

Maggie L. Shaw
These 48-week data from ARTISTRY-1 build on 24-week results previously presented and show enduring efficacy of bictegravir plus lenacapavir.
What We're Reading logo
July 25th 2024

What We’re Reading: Abortion Pill Restrictions; Rising Infant Mortality Rate; Shot Provides HIV Protection

AJMC Staff
A federal appeals court ruled yesterday that a group of Republican-led states do not have legal standing to impose restrictions on the abortion pill mifepristone; the US infant mortality rate increased by 3% in 2022; a twice-yearly injection could prevent 100% of HIV infections.
<12345678
...
33>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo